The Institute of NeuroPhysiopathology (INP) is a training and research centre of excellence that combines basic and translational research to study neural cell organisation, function and interaction, the molecular and cellular bases of major brain diseases, and to develop innovative cellular and molecular therapeutic strategies.
The PFNT Facility is a coherent set of exploration tools in neurobiology allowing research at the molecular, cellular and integrated levels.
The NeuroCyto team has a new publication out! Published on Sep. 15 in Neuron, this article reveals how clathrin is slowly transported along axons by forming transport packets that are then docked at presynapses where they can dynamically supply clathrin for synaptic function. This is another episode of the long-standing collaboration between the NeuroCyto team and the lab of Subhojit Roy at UCSD. Read the article here: https://doi.org/10.1016/j.neuron.2021.08.016
Nadia Coliac a été l’auteure, metteuse en scène et scénographe d’une expérience théâtrale bioluminescente qui a eu lieu le 19 octobre dernier à Paris sur la scène des arts et des sciences du théâtre de la Reine Blanche. Une expérience grandeur nature d'éclairer tout un théâtre uniquement avec la lumière vivante qui a captivé le public, ce fut un moment magique !
Cette production artistique et scientifique fait partie de ses recherches dans le domaine de l'histoire des sciences pour réhabiliter la mémoire de " Raphaël Dubois génie de la lampe vivante".
PINT platform recently acquired the NT.Robotic Autosampler that complemented the existing Prometheus NT.Plex nanoDSF instrument which is already equipped with aggregation detection optics to get complete stability characterization.
NT.Robotic Autosampler is a stand-alone, all-inclusive system with robotic arm, computer, and monitor. PINT is now able to analyze up to 1,536 samples for hands-free characterization of thermal unfolding and chemical denaturation in a single experiment. Incorporate plate temperature control to keep your samples at 4 to 20 °C while they wait in the queue.
This will permit to scale up the existing applications of the Prometheus :
Romain La Rocca, former member of INP team 9, shared the stage of EuroTau meeting in Lille's Grand Palais with Illana Gozes (Israel), Cláudio M. Gomes (Portugal), Amandine Grimm (Switzerland), Yann Fichou (France), Marina Rierola (Germany), Laura Vallés Saiz (Spain), Marie Galas (France) and Mahmoud Maina (UK / USA) during Session #3 chaired by Isabelle Landrieu & Yann Fichou.
He presented his PhD work on the Three zinc binding sites of Tau and their role in tau aggregation and little bit of the perspectives Dahbia Yatoui is currently working on right now.
On October, the 21st, Emmanuel was invited to give a talk during the 2021 meeting organized by the French Club of Glial Cells. Emmanuel had the chance to present the latest and exciting results of the NIVET team by giving a talk during a symposium dedicated on Glial cells in Brain diseases. Emmanuel's talk was entitled: "Human-iPSC-astrocytes reveal a pro-inflammatory axis under the control of the APOE4 genetic risk factor in Alzheimer's disease".
Félicitations à Chiara Bastiancich, post-doctorante dans l'équipe GlioME qui a obtenu la bourse de recherche fondamentale Élie Bzoura 2021, délivrée par la Société Française de Pharmacie Oncologique et à l' Académie nationale de Pharmacie pour son projet GlioRET.
Congratulations to Chiara Bastiancich, post-doctoral fellow in the GlioME team who has been awarded the Élie Bzoura research grant by the French Society of Oncology Pharmacy and the French National Academy of Pharmacy for her GlioRET project.
Aurélie Tchoghandjian (équipe 8 - GlioME) a obtenu un financement "Emergence" pour son projet intitulé "Création d’une lignée syngénique murine de cellules souches de glioblastome reproduisant l’hétérogénéité moléculaire et cellulaire des glioblastomes pour combattre la résistance thérapeutique" et Gilles Breuzard (équipe 9 - Cytosquelette et Physiopathologie) pour son projet intitulé "La protéine Tau comme nouvelle cible thérapeutique des glioblastomes : focus sur de nouveaux dérivés des thiazoloflavones "
Our team is please to welcome Chisato Suematsu for a 6 months Master internship (from September 2021). Originated from Japan, Chisato is currently studying at the University of Oldenburg (Germany) where she is enrolled in the Neuroscience Program as a 2nd year master student. She is one of the 3 international students that have been selected by NeuroMarseille to receive a competitive fellowship in the context of the MSc incoming mobility 2021 call.
If you want to know more about the treatment of glioblastoma with Gold Nanorods, click on the title "Well-Defined Polyethylene Glycol Microscale Hydrogel Blocks Containing Gold Nanorods for Dual Photothermal and Chemotherapeutic Therapy" , a publication co-authored by Chiara Bastiancich, post-doc in the GlioME team.
To nicely end 2021 year, Dominika Pilat, student in Neural Plasticity and Degeneration Team (Team 1), successfully defended her thesis on the 16th of December. She gave a very clear, precise and comprehensive presentation highlighting the pivotal role of MT5-MMP in the neuroinflammation in an Alzheimer’s Disease model.
Participating in the virtual conference "Tumor Microenvironment Heterogeneity in Cancer Progression: Challenge or Opportunity", Emmanuel Snacel-Fazy, a 2nd year PhD student in the GlioME team won the prize for the best presentation on the "Remodeling of the glioblstoma immune landscape by smac mimetic GDC-0152".
On February 22nd at 1 pm don't miss the next Neurobinar of NeuroMarseille !
Within the cycle M&M’s – Muscle Monday Seminars of the Institute’s Myology Centre for Research, on January 17 Michel Khrestchatisky (CNRS Research Director, Director of the Institute for Neurophysiopathology) Co-Founder & Scientific Counsel of Vect-Horus presented the conference entitled “"Development of molecular vectors for targeted delivery of RNAi via receptor-mediated transport".
Vect-Horus annonce l’accord de la Région SUD Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de plus d’un million d’euros. Ce projet est financé avec le concours de l’Union européenne avec le Fonds Européen de Développement Régional.
Pour plus d' information, lisez l'article complet dans BUSINESS WIRE.
The Institute of NeuroPhysiopathology (INP) at Aix-Marseille University/CNRS (https://www.univ-amu.fr/) combines basic and translational research in a stimulating and friendly working environment (https://inp.univ-amu.fr).
Type de contrat : CDD 24 mois
Date d'embauche prévue : au plus tard le 01/04/2022
Rémunération : selon expérience
Lieu : Aix-Marseille Université, Campus Timone, 27 boulevard Jean Moulin, 13005 Marseille
VECT-HORUS est une société de biotechnologie créée en 2005 et basée à Marseille spécialisée dans le développement de molécules vecteurs favorisant l’adressage de médicaments ou d’agents d’imagerie dans les organes, notamment le cerveau, et les tumeurs. Dans le cadre de l’accroissement et de la diversification de nos activités nous recherchons un.e Ingénieur.e spécialisé.e dans les approches histologiques.
Aix Marseille Université | All rights reserved - Legal notice
